Digital health and pharma – adapting to the post-coronavirus paradigm
The need for digital transformation and a response model for coronavirus were among the topics discussed in a recent digital debate
The coronavirus pandemic has brought about a digital-first transformation as society adapts to life during COVID-19. For life science companies the evolving paradigm offers many digital health opportunities.
A recent pharmaphorum webinar examined the ways that health technology can be used to develop public utility projects and enhance healthcare communications, and how the current health emergency has made the pharmaceutical industry’s ongoing need for digital transformation even more pressing.
The 10 years in 10 days: the new global digital health paradigm in life sciences webinar, held in association with Healthware Group, also proposed a response model for COVID-19 and addressed the deep transformation of marketing, customer engagement and adaptation of business processes.